Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models

Multiple myeloma is a plasma cell malignancy, which develops in the bone marrow and frequently leads to severe bone destruction. Current antiresorptive therapies to treat the bone disease do little to repair damaged bone; therefore, new treatment strategies incorporating bone anabolic therapies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Paton‐Hough, Julia, Tazzyman, Simon, Evans, Holly, Lath, Darren, Down, Jenny M, Green, Alanna C, Snowden, John A, Chantry, Andrew D, Lawson, Michelle A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607020/
https://www.ncbi.nlm.nih.gov/pubmed/30320927
http://dx.doi.org/10.1002/jbmr.3606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607020/
https://www.ncbi.nlm.nih.gov/pubmed/30320927
http://dx.doi.org/10.1002/jbmr.3606

Ejemplares similares